NeueHealth Inc.

NYSE: NEUE · Real-Time Price · USD
6.63
-0.09 (-1.37%)
At close: Aug 15, 2025, 2:05 PM

NeueHealth Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
890.44M 907.35M 936.66M 996.89M 1.03B 1.11B 1.62B 1.88B 3.24B 4.52B 5.6B 6.01B 5.45B 4.99B 4.03B 3.43B 2.7B 1.88B
Cost of Revenue
674.89M 706.16M 742.14M 822.11M 865.86M 933.34M 1.42B 1.16B 933.67M -738.77M -1.43B -1.43B -1.43B n/a n/a n/a n/a n/a
Gross Profit
215.55M 201.19M 194.52M 174.78M 167.5M 172.01M 191.62M 715.03M 2.3B 5.26B 7.02B 7.43B 6.88B 4.99B 4.03B 3.43B 2.7B 1.88B
Operating Income
-29.84M -81.65M -107.41M -123.93M -569.36M -555.23M -617.87M -643.33M -233.86M -279.17M -290.25M -183.63M -426.6M -416.91M -342.93M -538.19M -301.17M -269.36M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 948K 948K 948K 948K n/a n/a n/a
Pretax Income
-60.88M -107.14M -99.46M -117.55M -577.02M -570.16M -670.04M -801.27M -576.18M -792.02M -875.88M -1.51B -1.54B -1.36B -1.2B -547.05M -309.65M -273.7M
Net Income
-95.38M -130.5M -134.68M -361.67M -938.15M -992.36M -1.15B -1.6B -1.27B -1.44B -1.46B -1.59B -1.59B -1.35B -1.18B -534.18M -292.77M -266.32M
Selling & General & Admin
145.15M 211.35M 273.69M 245.36M 251.24M 249.62M 316.5M 353.08M 372.46M 386.87M 354.45M 513.7M 737.91M 919.98M 1.03B 923.97M 711.56M 539.33M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
407.54M 138.51M -146M -189.44M -295.77M -296.51M -375.35M -487.49M -776M -1.09B -1.37B -1.58B -1.5B -1.38B -951.76M -580.86M -267.27M n/a
Operating Expenses
552.7M 432.08M 290.33M 286.99M 318.48M 319.22M 398.06M 487.49M 776M 1.09B 1.37B 1.58B 1.5B 1.38B 1.85B 2B 2.1B 2.16B
Interest Expense
25.18M 22.41M 18.7M 23.66M 28.29M 33.35M 38.2M 33.38M 28.25M 19.41M 12.82M 8.11M 4.8M 8.6M 7.96M 6.28M 4.69M 546K
Selling & Marketing Expenses
-210K n/a n/a -1.08M -994K -574K 19.77M -145.89M -145.83M -146.46M -166.81M 313K n/a n/a n/a n/a n/a n/a
Cost & Expenses
1.23B 634.46M -7.82M 68.81M 144.05M 716.05M 1.82B 768.92M -1.32B -3.46B -6.31B -7.39B -6.98B -6.34B -3.43B -1.12B 660.48M 2.16B
Income Tax Expense
2.21M 2.04M 2.6M 4.86M -1.32M -2.02M -1.43M -7.25M -2.1M 1.7M 3.68M -389K -2.08M -24.45M -26.52M -18.22M -18.3M 10.33M
Shares Outstanding (Basic)
8.75M 8.57M 8.23M 8.28M 8.25M 8.08M 7.95M 7.98M 7.96M 7.89M 7.88M 7.87M 7.87M 7.86M 7.86M 7.85M 7.82M 1.75M
Shares Outstanding (Diluted)
8.75M 8.57M 8.23M 8.28M 8.25M 8.08M 7.95M 7.98M 7.96M 7.89M 7.88M 7.87M 7.87M 7.86M 7.86M 7.85M 7.82M 1.75M
EPS (Basic)
-15.98 -20.45 -19.52 -46.46 -117.42 -124.49 -144.69 -202.07 -161.48 -182.23 -184.9 -202.3 -201.71 -172.48 -162 -154.01 -150.49 -155.45
EPS (Diluted)
-15.98 -20.45 -19.52 -46.46 -117.42 -124.49 -144.69 -202.07 -161.48 -182.23 -184.9 -202.3 -201.71 -172.48 -162 -154.01 -150.49 -155.45
EBITDA
-51.82M -70.09M -65.11M -77.82M -532.05M -519.44M -558.81M -446.89M -82.27M -99.46M -237.87M -1.11B -1.29B -1.31B -1.16B -513.27M -287.77M -261.07M
EBIT
-49.4M -84.73M -80.76M -93.89M -548.74M -536.81M -590.97M -485.42M -108.7M -156.8M -271.01M -1.15B -1.35B -1.33B -1.2B -540.76M -304.96M -273.16M
Depreciation & Amortization
14.22M 14.64M 15.65M 16.07M 16.68M 17.38M 22.7M 29.08M 38.87M 47.43M 50.58M 49.68M 49.98M 43.94M 53.74M 204.26M 249.31M 269.36M